En ole huomannut täällä vielä puhetta tällaisesta pienestä kanadalaisesta telehealth tai sen välitys yhtiöstä (50m mc).Yhtiötä kuvailtu “lääkärien uberiksi”. Kurssi alkanut piristymään ja Q4 oletetaan olevan voitollinen kvartaali eli käännettä odotetaan. Toimintaa jo 50:ssä osavaltiossa. tutustukaa ihmeessä
5 Likes
1 Like
Yhtälujaa tullaan näillä myös alas! Pitkä aika odottaa Q4 tuloksia 
1 Like
VANCOUVER, British Columbia and LAS VEGAS, Feb. 27, 2025 (GLOBE NEWSWIRE) – Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing mobile clinical network and medical platform offering flexible, at-home healthcare services across all 50 U.S. states, is pleased to announce the expansion of its VSDHOne platform with a new suite of oral weight loss therapies in three convenient delivery formats: sublingual, capsule, and tablet.
This expansion strengthens Hydreight’s leadership in telehealth innovation while positioning the company to participate in the booming global weight loss market.
Next-Generation Oral Weight Loss Solutions—Accessible Nationwide
Hydreight’s new offerings provide patients with flexible, needle-free options for safe and effective weight loss treatments, conveniently delivered from the comfort of their homes, offices, or hotels.
New Weight Loss Treatments Include:
-
Semaglutide Sublingual – A Needle-Free GLP-1 Therapy
- Mimics natural hormones to regulate hunger and metabolism
- Reduces cravings without the need for injections
- Improves blood sugar regulation
- Supports long-term weight management
-
Sermorelin Sublingual – Natural Growth Hormone Stimulation
- Enhances natural growth hormone production
- Supports fat metabolism and lean muscle growth
- Improves sleep quality and overall vitality
-
Advanced Weight Management Support Capsule (Naltrexone / Bupropion / Metformin / Topiramate / Methylcobalamin)
- Controls appetite and reduces cravings
- Enhances metabolic function and energy levels
- Improves insulin sensitivity and portion control
- Boosts long-term weight management success
-
Metformin HCl ER Tablets – Sustained Metabolic Support
- Regulates blood sugar levels for improved metabolism
- Aids in appetite control
- Supports sustained energy throughout the day
-
Phentermine HCl Tablets (37.5 mg) – Appetite Suppressant & Metabolism Booster
- Suppresses appetite to aid in calorie control
- Increases energy levels to support physical activity
- Stimulates metabolism under physician-guided treatment
Three Flexible Delivery Formats Tailored for Convenience
Hydreight now offers patients greater flexibility with three convenient ways to take their medications:
- Sublingual Drops: Quick absorption under the tongue for fast-acting results
- Capsules: Easy-to-swallow with controlled release for sustained effectiveness
- Tablets: Flexible and gradual release for consistent dosing
Expanding Access to Safe, Effective Weight Loss Solutions
“With obesity rates on the rise and demand for accessible solutions growing rapidly, Hydreight’s expansion into oral weight loss therapies is a natural progression of our commitment to patient-centric healthcare,” said Shane Madden, CEO of Hydreight Technologies Inc.
“Our nationwide telehealth platform offers flexible, effective treatments that patients can access safely and conveniently from anywhere in the United States. With a network of over 3,000 licensed nurses and 100+ doctors across all 50 states, Hydreight ensures compliance, personalized care, and exceptional convenience for every patient.”
Why This Matters for Investors
The global weight loss industry is expected to exceed USD $400 billion by 2030 as demand for non-invasive, effective solutions surges. Hydreight’s fully operational, scalable platform gives it a first-mover advantage in the telehealth weight loss space.
With its fully integrated telehealth platform, Hydreight offers investors exposure to a fast-growing sector with high demand for safe, science-backed, and convenient weight loss treatments.
Key Advantages:
First-mover advantage in nationwide telehealth weight loss treatments- Rapid growth driven by rising demand for at-home healthcare solutions
- Positioned to gain market presence in the booming global weight loss industry
The Company has engaged GRA Enterprises LLC DBA National Inflation Association (“NIA”) for a term of three months from February 27, 2025, which can be extended at the option of the Company, to provide distribution and exposure of the Company’s activities through email distribution lists, website hosting, and blog posts, as well as interviews and technical updates to build awareness of the Company. NIA is based in Mooresville, North Carolina and has received a total fee of US$30,000 in consideration for services to be provided through the term of the engagement. The engagement of NIA is subject to the approval of the TSX Venture Exchange.
On behalf of the Board of Directors
Shane Madden
Director and Chief Executive Officer
Hydreight Technologies Inc.
2 Likes
Slightly profitable Q4. Q1 shows the direction for VSDHone license sales.
2 Likes
Just a quick update. VSDH one is growing well. ATH.
Financing secured and the train keeps moving!
Forecasts exceeded and the rocket gets more fuel!
1 Like
Could someone explain what kind of scam hit this one, with the stock down -26%, even though the Q3 figures seemed good? 
Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and
I couldn’t find Q3 forecasts anywhere to compare how it stacked up against them, but those growth figures are fine by me.
Or did they do some kind of offering?
I found somewhere on Yahoo that the EPS forecast (one analyst?) was missed by 66% (a very small EPS anyway still)… but this is a growth company that has only just become profitable, so I don’t see the point of EPS at this stage, but rather revenue and customer numbers, as long as it remains profitable and doesn’t need too much debt/offerings for growth.
1 Like
The communication in yesterday’s webinar regarding subscription numbers was quite weak, and it felt like questions about them were avoided. On Discord, they have tried to clarify the situation. Subscription numbers by early November are 501k and still remain on target for 1.3m… We’ll see if a PR comes before Monday’s opening.
1 Like
A stock exchange release was published today.
1 Like